|
Report No. : |
302752 |
|
Report Date : |
12.01.2015 |
IDENTIFICATION DETAILS
|
Correct Name : |
CENTRAL PHARMACEUTICAL COMPANY NO 2 |
|
|
|
|
Registered Office : |
334 To Hien Thanh St Ward 14, District 10, Ho Chi Minh |
|
|
|
|
Country : |
Viet Nam |
|
|
|
|
Financials (as on) : |
01.12.2012 |
|
|
|
|
Date of Incorporation : |
18.08.2010 |
|
|
|
|
Legal Form : |
Government-owned Enterprise |
|
|
|
|
Line of Business : |
Trader of Medical Equipment & Pharmaceutical |
|
|
|
|
No. of Employees : |
500 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
Vietnam |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
VIETNAM - ECONOMIC OVERVIEW
Vietnam is a
densely-populated developing country that has been transitioning from the
rigidities of a centrally-planned economy since 1986. Vietnamese authorities
have reaffirmed their commitment to economic modernization in recent years.
Vietnam joined the World Trade Organization in January 2007, which has promoted
more competitive, export-driven industries. Vietnam became an official
negotiating partner in the Trans-Pacific Partnership trade agreement in 2010.
Agriculture's share of economic output has continued to shrink from about 25%
in 2000 to less than 22% in 2012, while industry's share increased from 36% to
nearly 41% in the same period. State-owned enterprises account for roughly 40%
of GDP. Poverty has declined significantly, and Vietnam is working to create
jobs to meet the challenge of a labor force that is growing by more than one
million people every year. The global recession hurt Vietnam's export-oriented
economy, with GDP in 2012 growing at 5%, the slowest rate of growth since 1999.
In 2012, however, exports increased by more than 18%, year-on-year; several
administrative actions brought the trade deficit back into balance. Between
2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of 20%,
but its value remained stable in 2012. Foreign direct investment inflows fell
4.5% to $10.5 billion in 2012. Foreign donors have pledged $6.5 billion in new
development assistance for 2013. Hanoi has oscillated between promoting growth
and emphasizing macroeconomic stability in recent years. In February 2011, the
government shifted from policies aimed at achieving a high rate of economic
growth, which had stoked inflation, to those aimed at stabilizing the economy,
through tighter monetary and fiscal control. Although Vietnam unveiled a broad,
"three pillar" economic reform program in early 2012, proposing the
restructuring of public investment, state-owned enterprises, and the banking
sector, little perceptible progress had been made by early 2013. Vietnam's
economy continues to face challenges from an undercapitalized banking sector.
Non-performing loans weigh heavily on banks and businesses. In September 2012,
the official bad debt ratio climbed to 8.8%, though some independent analysts
believe it could be higher than 15%.
|
Source
: CIA |
|
Company Details |
|
Organization Name |
: |
CENTRAL PHARMACEUTICAL COMPANY NO 2 |
|
Address |
: |
334 To Hien Thanh St Ward 14, District 10, Ho Chi Minh |
|
Country |
: |
Vietnam |
|
Phone (S) |
: |
[+84] 8-38650593 |
|
Facsimile |
: |
[+84] 8-38650750 |
|
Email |
: |
coduphacantho@yahoo.com.vn |
|
Website |
: |
|
|
Primary Business Activity |
: |
Trader |
|
Key Industry |
: |
Medical Equipment & Pharmaceutical |
|
Key Facts |
|
Registered Legal Address |
: |
334 To Hien Thanh St Ward 14, District 10, Ho Chi Minh |
||||||
|
Operational Address |
: |
334 To Hien Thanh St Ward 14, District 10, Ho Chi Minh |
||||||
|
Trading Name |
: |
CODUPHA |
||||||
|
Name History |
: |
|
||||||
|
Issuing Authority |
: |
Dept. of Planning & Investment - Ho Chi Minh |
||||||
|
License Number |
: |
0300483319 |
||||||
|
License Status |
: |
License exists - Normal. |
||||||
|
Legal Form - Category |
: |
Government-owned Enterprise |
||||||
|
Legal Form |
: |
Company |
||||||
|
Legal Form - Abbreviation |
: |
CO |
||||||
|
Operational Status of Business |
: |
Normal |
||||||
|
Date of Registration |
: |
18 Aug, 2010 |
||||||
|
Employees |
: |
500 |
||||||
|
Capital |
: |
US$ 4,873,740 |
|
|
Report Details |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
COMPANY MANAGEMENT |
||||||||||||||||||||
|
|
Management Listings |
||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||
|
|
COMPANY DIRECTORS |
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
REPUTATION |
|
|
Reference checking for the purpose of establishing the CENTRAL
PHARMACEUTICAL COMPANY NO 2's reputation within the respective industry
failed to reveal any adverse information. |
|
|
NEGA-SCAN - ADVERSE DATA MONITORING |
|
|
|
|
|
CAPITAL (Currency: VND - Vietnam Dong) |
|||
|
|
|
|
SHAREHOLDERS |
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
PAYMENT TERMS |
||||||||||
|
Selling |
||||||||||
|
||||||||||
|
Purchasing |
||||||||||
|
Na
Financials - Summary (Currency: USD - US Dollar)
|
Year |
Sales |
Assets |
Net
Income |
|
2011 Annual |
118,201,056
|
58,370,955
|
819,683
|
|
2012 Annual (*) |
129,635,874
|
62,838,481
|
926,162
|
Sales Trend – Analysis
|
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Note: (*)
Financials listed are the most recent available for this
company.
|
|
FINANCIAL STATEMENT - DETAILED |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Balance Sheet |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Income Statement |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Financial Ratios |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Based on the corporate laws of Vietnam, legal entities which
are Government-owned Enterprise are not required to make public disclosure of
their annual financials. Although financials were obtained for reference. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Na
Primary Products
|
Products / Materials / Services Description |
Activity |
|
Pharmaceutical products |
Trading |
International Trade - Statistics (Currency: USD -
US Dollar)
|
Year |
Imports |
Exports |
Total |
|
2011 |
n/a |
11,820,106
|
11,820,106
|
|
|
SIC PRODUCT CLASSIFICATION & ACTIVITY |
||||||
|
|
|
|
|
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY |
|||||||||
|
|
|
|
|
CORE BUSINESS DESCRIPTION |
|
|
Core Business |
|
|
The primary business focus of CENTRAL PHARMACEUTICAL COMPANY
NO 2 is Trading - Finished products. ·
Pharmaceutical
products |
|
|
Supplementary Business |
|
|
In addition to the core business, CENTRAL PHARMACEUTICAL
COMPANY NO 2 also is engaged in the following areas of business: 1. Exporting ·
Exporting - Finished
products 2. Importing ·
Importing - Finished
products |
|
DOMESTIC SALES & PURCHASES |
||||||||
|
||||||||
|
|
|
BANK DETAILS |
|||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
LOCAL BRANCHES & MANAGEMENT |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
INTERNATIONAL TRADE - Activity & Markets |
|
|
|
|
|
COMPETITORS |
||
|
|
The following is a representative
list of local competitors: |
||
|
|
|
|
|
OFFICE & FACILITIES |
|||||||||||||||
|
|
The following information
relates to the Business Entity's office as listed above: |
|||||||||||||||
|
|
|
|||||||||||||||
|
|
COMPANY HISTORY |
|||||||||||||||
|
|
|
|
|
PREVIOUS CONTACT DETAILS |
|||
|
|
|
|
|
|
||||||
|
|
PREVIOUS BUSINESS LICENSE/S |
||||||
|
|
|
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.40 |
|
|
1 |
Rs.94.17 |
|
Euro |
1 |
Rs.73.61 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.